TDI-11861 is an orally active soluble sAC inhibitor optimized and designed based on TDI-10229 ( HY-132298 ), with an IC 50 of 3.3 nM and a K D of 1.4 nM. TDI-11861 has advantages such as high affinity, slow dissociation, and good pharmacokinetics. TDI-11861 can be used for research on male contraception and related sAC pharmacology.
Products | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Others | Products > Signaling Pathways > Adenylate Cyclase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.